APA (7th ed.) Citation

Li, C., Li, C., Li, C., Wang, J., Yang, H., Luo, S., & Lu, Q. (2025, January). Oxyberberine alleviates lipopolysaccharide-induced intestinal barrier disruption and inflammation in human colonic Caco-2 cells in vitro. Frontiers in Pharmacology.

Chicago Style (17th ed.) Citation

Li, Cailan, Cailan Li, Cailan Li, Jiahao Wang, Hongmei Yang, Shuang Luo, and Qiang Lu. "Oxyberberine Alleviates Lipopolysaccharide-induced Intestinal Barrier Disruption and Inflammation in Human Colonic Caco-2 Cells in Vitro." Frontiers in Pharmacology Jan. 2025.

MLA (9th ed.) Citation

Li, Cailan, et al. "Oxyberberine Alleviates Lipopolysaccharide-induced Intestinal Barrier Disruption and Inflammation in Human Colonic Caco-2 Cells in Vitro." Frontiers in Pharmacology, Jan. 2025.